Triple Inhaled Therapy in COPD. Reply
N Engl J Med
.
2020 Oct 1;383(14):1394-1395.
doi: 10.1056/NEJMc2026881.
Authors
Klaus F Rabe
1
,
Fernando J Martinez
2
,
Paul Dorinsky
3
Affiliations
1
LungenClinic Grosshansdorf, Grosshansdorf, Germany k.f.rabe@lungenclinic.de.
2
Weill Cornell Medicine, New York, NY.
3
AstraZeneca, Durham, NC.
PMID:
32997922
DOI:
10.1056/NEJMc2026881
No abstract available
Publication types
Letter
Comment
MeSH terms
Adrenergic beta-2 Receptor Agonists
Bronchodilator Agents*
Humans
Pulmonary Disease, Chronic Obstructive*
Substances
Adrenergic beta-2 Receptor Agonists
Bronchodilator Agents